Prosecution Insights
Last updated: July 17, 2026
Application No. 18/392,542

COLORANT CONTAINING ENCAPSULATED COPPER AS AN IN-CAN PRESERVATIVE

Non-Final OA §103
Filed
Dec 21, 2023
Priority
Dec 22, 2022 — provisional 63/434,582
Examiner
JONES, KOLTON ED
Art Unit
Tech Center
Assignee
BASF SE
OA Round
1 (Non-Final)
Grant Probability
Favorable
1-2
OA Rounds

Examiner Intelligence

Grants only 0% of cases
0%
Career Allowance Rate
0 granted / 0 resolved
-60.0% vs TC avg
Minimal +0% lift
Without
With
+0.0%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
13 currently pending
Career history
7
Total Applications
across all art units

Statute-Specific Performance

§103
100.0%
+60.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 0 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 13-24 are rejected under 35 U.S.C. 103 as being unpatentable over Reisacher (WO 2017012556 A1) in view of Gross (Copper-containing glass ceramic with high antimicrobial efficacy). Regarding claims 13-24, Reisacher teaches an aqueous pigment composition (Example 4; Claim 1) comprising: 40 wt.% pigment; 6 wt.% Ethoxylated/propoxylated polyethyleneimine (a water soluble polyamine wetting agent, consistent with accepted polyamines in paragraph [0025] of the instant specification); 0.4 wt% biocide; 0.5 wt.% defoamer (balance) water Reisacher also teaches the optional component of fungicides (page 6, line 4). Reisacher does not teach glass-encapsulated copper particles as a biocide. Gross teaches a paint comprising copper (I) glass-encapsulated biocidal particles (introduction). The glass-copper particle have an average size of 2.5 - 5.0µm (Results and Discussion, page 3). It would have been obvious to one of ordinary skill in the art as of the effective filing date of the instant application to see the usefulness of the glass-encapsulated copper of Gross in paints as a biocide and substitute the biocide found in Reisacher with the glass-encapsulated copper of Gross and the results would have been predictable. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Lahiri (US 20190029261 A1) Lahiri (US 20180289010 A1) Miller (US 11814532 B1) All references cited above teach glass-containing copper as a biocide in paint. Any inquiry concerning this communication or earlier communications from the examiner should be directed to KOLTON JONES whose telephone number is (571)272-9802. The examiner can normally be reached Generally Monday-Friday 8:00 am - 5:00 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at (517)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KOLTON JONES/Examiner, Art Unit 1763 /JOSEPH S DEL SOLE/Supervisory Patent Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Dec 21, 2023
Application Filed
Jun 24, 2026
Non-Final Rejection mailed — §103 (current)

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
Grant Probability
Low
PTA Risk
Based on 0 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month